CCL2 has the ability to draw CCR2-positive monocytes into the tumor microenvironment, prompting their differentiation into TAMs, ultimately fostering tumor growth and metastatic processes (96, 97) (Table 1). The gene discussed is CCL2; the disease is neoplasm.